FIORICET Side Effects

6260248-0 | Abdominal Pain Upper, Stevens-johnson Syndrome
on Jun 29, 2009 Male patient from UNITED STATES , child 8 years of age, weighting 52.91 lb, was diagnosed with migraine (What is migraine?), attention deficit/hyperactivity disorder and was treated with Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, stevens-johnson syndrome. Fioricet dosage: Unk. During the same period patient was treated with VYVANSE (20 Mg, Daily) (View Vyvanse Review and Vyvanse Label ), ADDERALL 10 (5 Mg, Unk) (View Adderall 10 Review and Adderall 10 Label ). Patient was hospitalized.

6066758-3 |
Patient was taking Fioricet (View Usage). on Jan 28, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, . Fioricet dosage: . During the same period patient was treated with HYDROCODONE BITARTRATE/ACETAMINOPHEN 5/500 (WATSON LABORATORIES) (View Hydrocodone Bitartrate/acetaminophen 5/500 (watson Laboratories) Review and Hydrocodone Bitartrate/acetaminophen 5/500 (watson Laboratories) Label ), CARISOPRODOL (WATSON LABORATORIES) (View Carisoprodol (watson Laboratories) Review and Carisoprodol (watson Laboratories) Label ).

6066659-0 |
Adverse event was reported on Jan 28, 2009 by a Male patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, . During the same period patient was treated with TRAMADOL HYDROCHLORIDE (Unk) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6051645-7 | Cough, Malaise, Nausea
on Jan 21, 2009 Female patient from UNITED STATES , 35 years of age, weighting 120.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: cough, malaise, nausea (What is nausea?). Fioricet dosage: 1 Every 4 Hours Po.


6019705-4 | Angioedema
on Dec 18, 2008 Male patient from INDIA , child 4 years of age, was diagnosed with viral infection (What is viral infection?) and was treated with Fioricet (View Usage). Patient had the following side effects: angioedema. Fioricet dosage: 15 Mg/kg For Two Doses. Patient was hospitalized.

6011837-X | Confusional State, Disturbance In Attention, Dysarthria, Feeling Drunk, Malaise, Neck Injury, Road Traffic Accident, Whiplash Injury
Patient was taking Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: confusional state, disturbance in attention, dysarthria, feeling drunk, malaise, neck injury, road traffic accident, whiplash injury on Feb 14, 2008 from UNITED STATES Additional patient health information: Female patient , 45 years of age, . Fioricet dosage: (denied Overdose), Oral.

5979619-2 | Hepatotoxicity
Adverse event was reported on Nov 24, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: 75 Mg/kg, Daily) was diagnosed with pyrexia, epilepsy (What is epilepsy?) and. Location: NETHERLANDS , child 7 years of age, Patient experienced the following unwanted or unexpected effects: hepatotoxicity. During the same period patient was treated with VALPROIC ACID /00228502/ (View Valproic Acid /00228502/ Review and Valproic Acid /00228502/ Label ), STIRIPENTOL (View Stiripentol Review and Stiripentol Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ).

5952310-4 | Metabolic Acidosis, Renal Impairment, Transaminases Increased, Urine Amino Acid Level Increased
on Nov 03, 2008 Male patient from UNITED KINGDOM , child 11 years of age, was diagnosed with nasopharyngitis and was treated with Fioricet (View Usage). Patient had the following side effects: metabolic acidosis, renal impairment, transaminases increased, urine amino acid level increased. Fioricet dosage: 500 Mg, Q6-8h. Patient was hospitalized.

5871974-7 | Cerebral Haemorrhage, Condition Aggravated, Hallucination, Auditory
on Aug 25, 2008 Female patient from UNITED STATES , 82 years of age, was treated with Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: cerebral haemorrhage, condition aggravated, hallucination, auditory. Fioricet dosage: Unk. Patient was hospitalized.

5843440-6 | Anion Gap Increased, Metabolic Acidosis, Pyroglutamate Increased
Patient was taking Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: anion gap increased, metabolic acidosis, pyroglutamate increased on Aug 08, 2008 from NETHERLANDS Additional patient health information: Female patient , 52 years of age, was diagnosed with pain (What is pain?), staphylococcal infection (What is staphylococcal infection?) and. Fioricet dosage: Unk. During the same period patient was treated with FLUCLOXICILLIN (12 G, Daily) (View Flucloxicillin Review and Flucloxicillin Label ). Patient was hospitalized.

5812115-1 | Erythema Multiforme, Vanishing Bile Duct Syndrome
Adverse event was reported on Jul 07, 2008 by a Male patient taking Fioricet (View Usage) (Dosage: 600 Mg, Three Divided Doses For 2 Days) was diagnosed with pyrexia and. Location: JAPAN , child 8 years of age, Patient had the following side effects: erythema multiforme, vanishing bile duct syndrome. During the same period patient was treated with CEFDINIR (300 Mg, Three Divided Doses For 2 Days) (View Cefdinir Review and Cefdinir Label ). Patient was hospitalized.

5788787-7 | Confusional State, Disorientation, Dyskinesia, Pain, Petit Mal Epilepsy, Self-injurious Ideation, Tic
on Jun 20, 2008 Female patient from UNITED STATES , weighting 102.0 lb, was diagnosed with pain (What is pain?), migraine (What is migraine?), multiple sclerosis (What is multiple sclerosis?), bipolar disorder (What is bipolar disorder?), agoraphobia, convulsion, oral herpes and was treated with Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: confusional state, disorientation, dyskinesia, pain (What is pain?), petit mal epilepsy, self-injurious ideation, tic (What is tic?). Fioricet dosage: 40-60 Tablets Daily. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), WELLBUTRIN (Unk) (View Wellbutrin Review and Wellbutrin Label ), REMERON (Unk) (View Remeron Review and Remeron Label ), SEROQUEL (Unk) (View Seroquel Review and Seroquel Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), VALTREX (Unk) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

5780855-9 | Confusional State, Disorientation, Dyskinesia, Petit Mal Epilepsy, Self-injurious Ideation, Tic
on Jun 10, 2008 Female patient from UNITED STATES , weighting 102.0 lb, was diagnosed with pain (What is pain?), migraine (What is migraine?), multiple sclerosis (What is multiple sclerosis?), bipolar disorder (What is bipolar disorder?), agoraphobia, convulsion, oral herpes and was treated with Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disorientation, dyskinesia, petit mal epilepsy, self-injurious ideation, tic (What is tic?). Fioricet dosage: 40-60 Tablets Daily. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), WELLBUTRIN (Unk) (View Wellbutrin Review and Wellbutrin Label ), REMERON (Unk) (View Remeron Review and Remeron Label ), SEROQUEL (Unk) (View Seroquel Review and Seroquel Label ), CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label ), VALTREX (Unk) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

5776843-9 | Acute Hepatic Failure, Alcohol Interaction
Patient was taking Fioricet (View Usage). Patient had the following side effects: acute hepatic failure, alcohol interaction on Jun 11, 2008 from SWITZERLAND Additional patient health information: Male patient , 75 years of age, was diagnosed with procedural pain, hypertension and. Fioricet dosage: 4 G, Of Paracetamol Daily. During the same period patient was treated with ALCOHOL /00002101/ (50 G, Daily) (View Alcohol /00002101/ Review and Alcohol /00002101/ Label ), RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Daily) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5776840-3 | Acute Hepatic Failure, Alcohol Interaction
Adverse event was reported on Jun 11, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: 4 G, Daily) was diagnosed with pain (What is pain?), coronary artery disease (What is coronary artery disease?) and. Location: SWITZERLAND , 84 years of age, After Fioricet was administered, patient had the following side effects: acute hepatic failure, alcohol interaction. During the same period patient was treated with METOPROLOL (50 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), ASPIRIN (100 Mg, Daily) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5740152-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatotoxicity
on May 08, 2008 Female patient from NETHERLANDS , child 3 years of age, was diagnosed with ill-defined disorder and was treated with Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatotoxicity. Fioricet dosage: . During the same period patient was treated with VALPROIC ACID (27 Mg/kg, Daily,) (View Valproic Acid Review and Valproic Acid Label ), TOPIRAMATE (8.4 Mg/kg, Daily,) (View Topiramate Review and Topiramate Label ), CLOBAZAM (CLOBAZAM) (View Clobazam (clobazam) Review and Clobazam (clobazam) Label ).

5712154-5 | Abdominal Pain Upper
on Apr 21, 2008 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with headache (What is headache?), diabetes mellitus and was treated with Fioricet (View Usage). Patient had the following side effects: abdominal pain upper. Fioricet dosage: . During the same period patient was treated with GLUCOVANCE (View Glucovance Review and Glucovance Label ).

5705315-2 | Hepatotoxicity
Patient was taking Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: hepatotoxicity on Apr 01, 2008 from AUSTRALIA Additional patient health information: Male patient , child 12 years of age, weighting 94.80 lb, was diagnosed with spinal operation and. Fioricet dosage: 3000 Mg, (70 Mg/kg) Over 24 H, Rectal; 3000 Mg (max 4650 Mg, 108 Mg/kg) X 5d, Rectal. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ). Patient was hospitalized.

5705254-7 | Hepatotoxicity
Adverse event was reported on Apr 01, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: 2400mg Divided Doses Over 72h, 2800 Mg, Over 17 H (140mg/kg)) was diagnosed with otitis media and. Location: AUSTRALIA , child 4 years of age, weighting 44.09 lb, Patient experienced the following unwanted or unexpected effects: hepatotoxicity. During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ). Patient was hospitalized.

5699343-3 | Aggression, Agitation, Amnesia, Anger, Energy Increased, Hallucination, Homicidal Ideation, Hostility, Impulsive Behaviour
on Mar 27, 2008 Male patient from UNITED STATES , child 12 years of age, was treated with Fioricet (View Usage). Patient had the following side effects: aggression, agitation, amnesia, anger, energy increased, hallucination, homicidal ideation, hostility, impulsive behaviour. Fioricet dosage: Oral. During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (Oral) (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ).

5677771-X | Acute Hepatic Failure
on Mar 06, 2008 Male patient from UNITED KINGDOM , 20 years of age, was treated with Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: acute hepatic failure. Fioricet dosage: 1 G Qid X10 Doses), Enterally. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

5677769-1 | Acute Hepatic Failure
Patient was taking Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure on Mar 06, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 42 years of age, . Fioricet dosage: 1g Doses(x12); 6dose Enterally, 6, Intravenous.

5676660-4 | Abdominal Discomfort
Adverse event was reported on Mar 20, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: Po Q 8-12 Secondary Prn) was diagnosed with headache (What is headache?) and. Location: UNITED STATES , 57 years of age, Patient had the following side effects: abdominal discomfort.

5648119-1 | Confusional State, Disturbance In Attention, Dysarthria, Emotional Disorder, Feeling Drunk, Malaise, Neck Injury, Road Traffic Accident
on Feb 14, 2008 Female patient from UNITED STATES , 45 years of age, was diagnosed with migraine (What is migraine?) and was treated with Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: confusional state, disturbance in attention, dysarthria, emotional disorder, feeling drunk, malaise, neck injury, road traffic accident. Fioricet dosage: (denied Overdose), Oral.

5637728-1 | Cardio-respiratory Arrest
on Feb 04, 2008 Male patient from UNITED STATES , 20 years of age, was treated with Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest. Fioricet dosage: . During the same period patient was treated with HEROIN(DIAMORPHINE) (View Heroin(diamorphine) Review and Heroin(diamorphine) Label ), OPIOIDS() (View Opioids() Review and Opioids() Label ).

5637715-3 |
Patient was taking Fioricet (View Usage). on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 44 years of age, . Fioricet dosage: . During the same period patient was treated with COCAINE(COCAINE) (View Cocaine(cocaine) Review and Cocaine(cocaine) Label ).

5637645-7 |
Adverse event was reported on Feb 04, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 15 years of age, .

5637643-3 |
on Feb 04, 2008 Female patient from UNITED STATES , 44 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: .

5637642-1 |
on Feb 04, 2008 Female patient from UNITED STATES , 53 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: . During the same period patient was treated with FIORINAL (View Fiorinal Review and Fiorinal Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

5637492-6 | Cardio-respiratory Arrest
Patient was taking Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: cardio-respiratory arrest on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 52 years of age, . Fioricet dosage: . During the same period patient was treated with TEMAZEPAM (View Temazepam Review and Temazepam Label ), OXAZEPAM (WATSON LABORATORIES)(OXAZEPAM) CAPSULE (View Oxazepam (watson Laboratories)(oxazepam) Capsule Review and Oxazepam (watson Laboratories)(oxazepam) Capsule Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CARDIAC GLYCOSIDES (View Cardiac Glycosides Review and Cardiac Glycosides Label ), POTASSIUM SPARING DIURETIC (View Potassium Sparing Diuretic Review and Potassium Sparing Diuretic Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5636640-1 | Hepatotoxicity, Liver Injury
Adverse event was reported on Feb 06, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: 650 Mg, Daily, 4days/wk, Oral) was diagnosed with osteoarthritis (What is osteoarthritis?), alcohol use and. Location: SPAIN , 58 years of age, Patient experienced the following unwanted or unexpected effects: hepatotoxicity, liver injury. During the same period patient was treated with PAROXETINE (X 8 Months, Oral) (View Paroxetine Review and Paroxetine Label ), ALCOHOL(ETHANOL) (Less Than 10 G, Daily, Oral) (View Alcohol(ethanol) Review and Alcohol(ethanol) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), VALERIANA DISPERT (VALERIANA OFFICINALIS ROOT) (View Valeriana Dispert (valeriana Officinalis Root) Review and Valeriana Dispert (valeriana Officinalis Root) Label ). Patient was hospitalized.

5636185-9 | Hepatotoxicity, Liver Injury
on Feb 06, 2008 Female patient from SPAIN , 58 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), alcoholic and was treated with Fioricet (View Usage). Patient had the following side effects: hepatotoxicity, liver injury. Fioricet dosage: 650 Mg, 1/week X Several Years, Oral. During the same period patient was treated with ALCOHOL(ETHANOL) (40 G, Daily; Oral) (View Alcohol(ethanol) Review and Alcohol(ethanol) Label ). Patient was hospitalized.

5636184-7 | Hepatotoxicity, Liver Injury
on Feb 06, 2008 Female patient from SPAIN , 85 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), alcohol use and was treated with Fioricet (View Usage). After Fioricet was administered, patient had the following side effects: hepatotoxicity, liver injury. Fioricet dosage: 1950 Mg, Daily X23 Fsys, Oral. During the same period patient was treated with ALCOHOL(ETHANOL) (Less Than 10 G, Daily, Oral) (View Alcohol(ethanol) Review and Alcohol(ethanol) Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5631561-2 |
Patient was taking Fioricet (View Usage). on Feb 04, 2008 from UNITED STATES Additional patient health information: Female patient , 33 years of age, . Fioricet dosage: . During the same period patient was treated with ETHANOL(ETHANOL) (View Ethanol(ethanol) Review and Ethanol(ethanol) Label ).

5631554-5 |
Adverse event was reported on Feb 04, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 39 years of age, .

5631553-3 |
on Feb 04, 2008 Male patient from UNITED STATES , 36 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: .

5631552-1 |
on Feb 04, 2008 Female patient from UNITED STATES , 36 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: .

5631551-X |
Patient was taking Fioricet (View Usage). on Feb 04, 2008 from UNITED STATES Additional patient health information: Female patient , 36 years of age, . Fioricet dosage: .

5631550-8 | Cardio-respiratory Arrest
Adverse event was reported on Feb 04, 2008 by a Male patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 36 years of age, After Fioricet was administered, patient had the following side effects: cardio-respiratory arrest. During the same period patient was treated with FIORINAL W/CODEINE (View Fiorinal W/codeine Review and Fiorinal W/codeine Label ), CYCLOBENZAPRINE HYDROCHLORIDE (View Cyclobenzaprine Hydrochloride Review and Cyclobenzaprine Hydrochloride Label ).

5631549-1 |
on Feb 04, 2008 Female patient from UNITED STATES , 33 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: . During the same period patient was treated with ETHANOL(ETHANOL) (View Ethanol(ethanol) Review and Ethanol(ethanol) Label ).

5631548-X |
on Feb 04, 2008 Female patient from UNITED STATES , 33 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: .

5631547-8 |
Patient was taking Fioricet (View Usage). on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 34 years of age, . Fioricet dosage: .

5631546-6 |
Adverse event was reported on Feb 04, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 28 years of age, .

5631545-4 |
on Feb 04, 2008 Female patient from UNITED STATES , 29 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: .

5631544-2 |
on Feb 04, 2008 Male patient from UNITED STATES , 29 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: . During the same period patient was treated with OXYCODONE HYDROCHLORIDE/APAP (ACETAMINOPHEN, OXYCODONE HYDROCHLO (View Oxycodone Hydrochloride/apap (acetaminophen, Oxycodone Hydrochlo Review and Oxycodone Hydrochloride/apap (acetaminophen, Oxycodone Hydrochlo Label ).

5631541-7 | Cardio-respiratory Arrest
Patient was taking Fioricet (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 25 years of age, . Fioricet dosage: .

5631540-5 |
Adverse event was reported on Feb 04, 2008 by a Female patient taking Fioricet (View Usage) (Dosage: ) . Location: UNITED STATES , 25 years of age, . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5631538-7 |
on Feb 04, 2008 Female patient from UNITED STATES , 26 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: . During the same period patient was treated with ETHANOL (ETHANOL) (View Ethanol (ethanol) Review and Ethanol (ethanol) Label ).

5631520-X |
on Feb 04, 2008 Female patient from UNITED STATES , 21 years of age, was treated with Fioricet (View Usage). . Fioricet dosage: . During the same period patient was treated with AMPHETAMINE ASP AMPHETAMINE SULF DEXTROAMPHET SACCHARATE + DEXTR SULF (View Amphetamine Asp Amphetamine Sulf Dextroamphet Saccharate + Dextr Sulf Review and Amphetamine Asp Amphetamine Sulf Dextroamphet Saccharate + Dextr Sulf Label ), COCAINE(COCAINE) (View Cocaine(cocaine) Review and Cocaine(cocaine) Label ).

5631499-0 | Cardio-respiratory Arrest
Patient was taking Fioricet (View Usage). Patient had the following side effects: cardio-respiratory arrest on Feb 04, 2008 from UNITED STATES Additional patient health information: Female patient , 39 years of age, . Fioricet dosage: . During the same period patient was treated with FIORINAL (View Fiorinal Review and Fiorinal Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), ANGIOTENSIN RECEPTOR BLOCKER() (View Angiotensin Receptor Blocker() Review and Angiotensin Receptor Blocker() Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), CAFFEINE CITRATE (View Caffeine Citrate Review and Caffeine Citrate Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ).